Buy or sell InterVenn stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

InterVenn Stock

InterVenn Biosciences identifies, quantifies, and classifies Glycoproteomic and other PTM signals found in human blood and tissue.

Founded

2017

Notable Investors

Anzu Partners

Headquarters

South San Francisco CA, US

Total Funding

$278M

About InterVenn Stock

InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM signals found in human blood and tissue for biomarker and target discovery. It specializes in the fields of biotechnology and life science. The company's VISTA is the first commercially available platform that can assess (serum or plasma) protein glycosylation in a site-specific manner, across thousands of peptides and glycopeptides. It was founded in 2017 and headquartered in Redwood City, California.

Investors

Funding History

December 2018$9.4M
July 2020$33.7M
November 2020$34.0M
August 2021$201M

Management

Scientific Co-Founder

Carolyn Bertozzi

Co-Founder and CEO

Aldo Carrascoso

Scientific Co-Founder

Carlito Lebrilla

SVP of QA, RA and Customer Excellence

Katherine Dalao

General Manager - Malaysia / VP Business Development

Fadzhairi Jabar

Chief Financial Officer

Brian Hogan

COO

Erwin Estigarribia

Country Manager

Axel Kornerup

Board of Directors

Adam D'Augelli

Investor

Sunil Dhaliwal

Board of Directors

Jenny Rooke

Advisor

Ryan Bethencourt

Senior Director of Pre-clinical R&D

Xin Cong

InterVenn Distinguished Scientist

Klaus Lindpaintner

Board Member

David Michael

Chief Medical Officer

Tillman Pearce

Director

Kenan Pandza

CBO

John Leite

Chief Data Officer

Dan Serie

VP, Clinical Development

Kaitlynn Moser

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo